FibroBiologics, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
FBLG on Nasdaq
Location
455 E. Medical Center Blvd, Suite 300, Houston, TX

Insiders trading volume in the past year

FibroBiologics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pete O'heeron CHIEF EXECUTIVE OFFICER, Director $11.3M Mar 26, 2025
Hamid Khoja Chief Scientific Officer $26.3K +$16.8K +178% May 27, 2025
Ruben A. Garcia General Counsel Mar 26, 2025
Mark Andersen Chief Financial Officer Jan 24, 2024
Richard C. Cilento Jr. Director Jun 12, 2025
Robert E. Hoffman Director Jun 12, 2025
Matthew Link Director Jun 12, 2025
Victoria Ninon Olivia Niklas Director Jun 12, 2025
Jason Davis Chief Financial Officer Jun 9, 2025
Stacy Ann Coen Director Jun 12, 2025

Recent Insider Transactions by Companies or Individuals for FibroBiologics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.